Sign In
Buy CLDX
$33.41
+0.98 (+3.02%)
At Close: Jun 22, 2026
Celldex Appoints Freddy A. Jimenez, Esq.
08:01am, Monday, 04'th Jan 2021
HAMPTON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced the promotion of Freddy A. Jimenez, Esq. to Senior Vice President and General Counsel, effecti
These 5 Small-Cap Healthcare Stocks Gained the Most in 2020
06:55am, Wednesday, 23'rd Dec 2020
These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.
These Were the 10 Best Healthcare Stocks of 2020
06:35am, Tuesday, 15'th Dec 2020
The highest performers of the year are biotechs fighting COVID-19 and cancer. Are they still buys for 2021?
Celldex Doses First Patient in Phase 1b Study of CDX-0159 in Chronic Inducible Urticaria
08:01am, Wednesday, 09'th Dec 2020
HAMPTON, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the first patient has been dosed in its open label clinical trial in cold contact urticar
Celldex Therapeutics to Present at 3rd Annual Evercore ISI HealthCONx Conference
04:01pm, Monday, 30'th Nov 2020
HAMPTON, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that the Company will participate in a fireside chat at the 3rd Annual Evercore ISI HealthCON
Celldex Presents Data from Oncology Portfolio at SITC 2020
08:01am, Monday, 09'th Nov 2020
-- A gonist anti-CD40 mAb CDX-1140 demonstrates best-in-class potential; additional expansion cohorts initiated-- --Axl and CDX-527 programs highlighted-- HAMPTON, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE)
Celldex Provides Corporate Update and Reports Third Quarter 2020 Results
04:01pm, Thursday, 05'th Nov 2020
HAMPTON, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2020.
Tricida Suffers Setback, And Other News: The Good, Bad And Ugly Of Biopharma
01:43am, Wednesday, 26'th Aug 2020
Tricida suffers setback on Veverimer front. CohBar advances its Phase 1b trial for NASH treatment.
Celldex Provides Corporate Update and Reports Second Quarter 2020 Results
08:01pm, Thursday, 06'th Aug 2020
\--Conference Call and Webcast today at 4:30pm ET--HAMPTON, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the se
Celldex to Report Second Quarter 2020 Financial Results and Host Corporate Update Call
12:01pm, Monday, 03'rd Aug 2020
HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on Thursday, August 6, 2020 after the U.S. financial markets
Celldex Therapeutics (CLDX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:33pm, Wednesday, 29'th Jul 2020
Celldex (CLDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Celldex Therapeutics (NASDAQ:CLDX) Downgraded to Hold at BidaskClub
05:48am, Sunday, 19'th Jul 2020
BidaskClub downgraded shares of Celldex Therapeutics (NASDAQ:CLDX) from a buy rating to a hold rating in a research note released on Wednesday, BidAskClub reports. A number of other research firms als
Celldex Therapeutics (NASDAQ:CLDX) Shares Pass Above 200 Day Moving Average of $3.69
01:56am, Tuesday, 14'th Jul 2020
Celldex Therapeutics, Inc. (NASDAQ:CLDX) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $3.69 and traded as high as $12.2
Top Ranked Momentum Stocks to Buy for July 9th
03:01pm, Thursday, 09'th Jul 2020
Top Ranked Momentum Stocks to Buy for July 9th
